The varying degree of disease severity in APDS patients raises the question as to whether rare activating mutations in genes encoding PI3Kδ or other proteins that regulate PI3K activity may be responsible for causing similar disorders, perhaps resembling only some of the APDS manifestations. This evidence concerns the gene PIK3CB and activated PI3K-delta syndrome.